BeOne Medicines Ltd.
ONC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651308
In the last 90 days, BeOne Medicines Ltd. insiders filed 0 open-market purchases and 9 sales; 285 institutions reported holding it in 13F filings for Q2 2026, worth $9.93B in total; no superinvestor holds it.
Other share classesBEIGF
Key figures
- Market capADS ratio not in SEC data
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $48.5M in total
- 9
- 13F holdersQ2 2026, +5 vs. previous quarter
- 285
- 13F valueReported value at the end of Q2 2026
- $9.93B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $5.34B
- +40.2% year over year
- Net income, FY2025
- $286.9M
- No comparable prior period
- Free cash flow, FY2025
- $941.7M
- No comparable prior period
- Revenue, Q3 FY2026
- $1.89B
- +33.8% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.60M
- Shares sold short
- Change
- −190.3K
- −10.6% vs. previous
- Days to cover
- 4.37
- At average daily volume
Superinvestors holding ONC, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding ONC at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by BeOne Medicines Ltd. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 (view filing)4:59 PM ET | Nov 6 | 4 days | Ball Titus B.Principal Accounting Officer | SSaleAmerican Depositary Shares | −1.56K | $405.57 | −$632.3K | −100.0%0 after | 2 lots |
| Nov 9, 2026 (view filing)5:13 PM ET | Nov 5 | 4 days | Lee Chan HenrySVP, General Counsel | SSaleAmerican Depositary Shares | −1.11K | $400.82 | −$446.9K | −100.0%0 after | 2 lots10b5-1 |
| Oct 29, 2026 (view filing)5:04 PM ET | Oct 27 | 2 days | Wang XiaodongDirector, Other: Chair, Scientific Advisory Brd | SSaleAmerican Depositary Shares | −31.0K | $362.97 | −$11.3M | −100.0%0 after | 11 lots10b5-1 |
| Oct 15, 2026 (view filing)5:08 PM ET | Oct 13 | 2 days | Wang XiaodongDirector, Other: Chair, Scientific Advisory Brd | SSaleAmerican Depositary Shares | −31.0K | $350.99 | −$10.9M | −100.0%0 after | 5 lots10b5-1 |
| Oct 2, 2026 (view filing)4:53 PM ET | Sep 30 | 2 days | Lee Chan HenrySVP, General Counsel | SSaleAmerican Depositary Shares | −1.11K | $375.00 | −$418.1K | −100.0%0 after | 10b5-1 |
| Sep 30, 2026 (view filing)5:11 PM ET | Sep 28 | 2 days | Wang XiaodongDirector, Other: Chair, Scientific Advisory Brd | SSaleAmerican Depositary Shares | −31.0K | $364.79 | −$11.3M | −100.0%0 after | 10 lots10b5-1 |
| Sep 10, 2026 (view filing)4:49 PM ET | Sep 8 | 2 days | Wang XiaodongDirector, Other: Chair, Scientific Advisory Brd | SSaleAmerican Depositary Shares | −38.3K | $349.10 | −$13.4M | −100.0%0 after | 8 lots10b5-1 |
| Sep 3, 2026 (view filing)5:17 PM ET | Sep 1 | 2 days | Ball Titus B.Principal Accounting Officer | SSaleAmerican Depositary Shares | −132 | $355.86 | −$47.0K | −100.0%0 after | |
| Aug 27, 2026 (view filing)5:12 PM ET | Aug 25 | 2 days | Wu XiaobinPresident and COO | SSaleAmerican Depositary Shares | −280 | $380.00 | −$106.4K | −100.0%0 after | 10b5-1 |
| Aug 13, 2026 (view filing)8:54 PM ET | Aug 11 | 2 days | Lee Chan HenrySVP, General Counsel | SSaleAmerican Depositary Shares | −2.67K | $360.00 | −$959.8K | −100.0%0 after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 285 holdersThe largest institutional positions in BeOne Medicines Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 8,801,567 | $2.51B | 12.57% | +2,5140.0% | Added |
| Primecap Management Co | 5,007,931 | $1.43B | 0.84% | +32,750+0.7% | Added |
| Capital International Investors | 4,210,221 | $1.20B | 0.25% | +51,495+1.2% | Added |
| FMR LLC | 2,478,527 | $706.3M | 0.03% | −1,215,083−32.9% | Reduced |
| Capital World Investors | 2,249,582 | $641.1M | 0.08% | +626,895+38.6% | Added |
| Citadel Advisors LLC | 1,425,517 | $406.2M | 0.23% | +393,219+38.1% | Added |
| Temasek Holdings (Private) Ltd | 845,729 | $241.0M | 0.66% | −16,914−2.0% | Reduced |
| Price T Rowe Associates Inc | 758,752 | $216.2M | 0.02% | +218,983+40.6% | Added |
| BlackRock, Inc. | 694,618 | $197.9M | 0.00% | +37,117+5.6% | Added |
| Millennium Management LLC | 543,323 | $154.8M | 0.10% | +338,477+165.2% | Added |
Holders of 5% or more of ONC
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of BeOne Medicines Ltd..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 13D/A | 7.80%115.9M shares | −0.20 ppfrom 8.00% | May 5, 20236 filings | Sep 16, 2026 | SEC |
Politician trades
All politician trades in ONC2 members of Congress reported 3 trades in BeOne Medicines Ltd. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Aug 13, 2023 |  Daniel S. Goldman House · NY | Sell | $1K-$15K |
| Aug 13, 2023 | Daniel S. Goldman House · NY | Sell | $1K-$15K |
| Dec 2, 2020 |  Greg Gianforte House · MT | Buy | $1K-$15K |
House · NY · Aug 13, 2023
Sell$1K-$15K
House · NY · Aug 13, 2023
Sell$1K-$15K
House · MT · Dec 2, 2020
Buy$1K-$15K